ArticleFrontiers in public health2025
Rising trends in the burden of migraine among children and adolescents: a comprehensive analysis from 1990 to 2021 with future predictions.
Article in Frontiers in public health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
7 citing papers in PubMed.
- Review
- Global burden shift from infectious to non-communicable neurological disorders in adolescents and young adults (10-24 years): findings from the global burden of disease study 1990-2021.International journal of clinical pharmacy · 2026Article
- Expanding preventive options for pediatric migraine: the use of anti-CGRP monoclonal antibodies for children and adolescents with migraine.Translational pediatrics · 2026Article
- Integrating Nutrition and Physical Activity into the EXEMIG/01 Interdisciplinary Model for Chronic and High-Frequency Migraine.Nutrients · 2026Article
- Pediatric migraine: Neurodevelopmental mechanisms, clinical phenotypes, and modern therapeutics.World journal of clinical pediatrics · 2026Review
- Disparities in Headache Care and Research in Children and Adolescents: A Narrative Review.Current pain and headache reports · 2026Review
- The HIT-6 Questionnaire Corresponds to the PedMIDAS for Assessment of Pediatric Headaches.Healthcare (Basel, Switzerland) · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Migraine is a leading neurological disorder among children and adolescents. Its high prevalence and risk of chronic progression significantly reduce quality of life and are linked to mental health issues and learning difficulties. Despite available diagnostic standards and treatments, global challenges remain, including underdiagnosis and unequal healthcare access, especially in developing countries where health systems are unprepared for rising cases. Analyzing long-term patterns and contributing factors of pediatric migraine is crucial for improving healthcare planning and prevention strategies. Methods: Using data from the Global Burden of Disease Study (GBD), this study analyzed migraine epidemiology in 5-19-year-olds across 204 countries and territories during 1990-2021. Disease burden trends were quantified through age-standardized rates (ASR) and estimated annual percentage changes (EAPC). Regions were categorized into five distinct tiers according to the Sociodemographic Index (SDI). Furthermore, a Bayesian age-period-cohort model was implemented to project disease burden trends through 2035. Results: From 1990 to 2021, global migraine cases among children and adolescents increased from 165,687,027.67 to 205,729,235.09, marking a 24.17% rise, with disability-adjusted life years (DALYs) growing by 24.38%. Low-middle SDI regions bore the heaviest disease burden, reporting 65,004,285.01 cases in 2021-triple that of high SDI regions. Females exhibited significantly higher prevalence, incidence, and DALYs than males. Trend analysis revealed declining disease burden in low-middle SDI regions but rising rates in high SDI regions. Despite projected declines in global age-standardized migraine prevalence, incidence, and DALYs by 2035, adolescents aged 15-19 are still anticipated to face disproportionately high disease burdens. Conclusion: The burden of migraine among children and adolescents exhibits significant geographical and gender heterogeneity, necessitating targeted optimization of healthcare resource allocation. Strengthening primary care diagnostic capacity, promoting standardized treatment guidelines, and prioritizing disease prevention and control in low-income regions are critical to alleviating the global burden.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.